Data / Form D filings / Rebalance Health, Inc.
Rebalance Health, Inc.: Form D filings
Rebalance Health, Inc., a biotechnology company in Boulder, CO, filed 4 Form D notices with the SEC between 2021 and 2023. The latest, on August 28, 2023, reports $7.4 million sold of a $10 million offering to 39 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1855 57th Court South, Boulder, CO, 80301
- Phone
- (844) 372-1844
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1869786
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 28, 2023 | New notice | $9,999,998 | $7,371,448 | $2,628,550 | 39 | Aug 18, 2023 | sec.gov |
| May 13, 2022 | New notice | $10,000,000 | $7,630,672 | $2,369,328 | 68 | Feb 16, 2022 | sec.gov |
| Nov 9, 2021 | Amendment | $6,700,000 | $6,699,999 | $1 | 96 | Dec 16, 2020 | sec.gov |
| Aug 4, 2021 | New notice | $5,005,000 | $4,249,979 | $755,021 | 72 | Dec 16, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Scott L. Glenn | Executive Officer, Director | |
| Randy A. Hetrick | Director | |
| Fabian C. Seelbach | Director | |
| Mark C. McKenna | Director | |
| Patrick A. Hopf | Director | |
| James B. Breitmeyer | Director | |
| Justin A. Hai | Executive Officer, Director |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of Aug 28, 2023 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Rebalance Health, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.